Expert Forum on Genomic Medicine

Conference Quickinfo
Date	22 - 23 Oct 2018
Location	Centre for Global Dialogue Rüschlikon, Zurich, Switzerland Click to open Google Map

Tab navigation

tab1

Open slide in overlay

Robert Green, Professor of Medicine, Harvard Medical School

Open slide in overlay

Rodger Novak, President and Chair of the Board of Directors, CRISPR Therapeutics

Open slide in overlay

Mark Bale, Head of Science Partnerships, Genomics England

Open slide in overlay

Richard Karlsson Linnér, Postdoctoral Researcher, Vrije Universiteit Amsterdam

Open slide in overlay

Colleen McBride, Rollins Proffessor and Chair, Emory University

Open slide in overlay

Lizzy Lubczanski, Behavioural Research Manager, Swiss Re

Open slide in overlay

Christoph Nabholz, Head Life & Behaviour R&D, Swiss Re

tab2

	Monday, 22 October 2018
18.00	Networking reception and dinner for speakers at the Centre for Global Dialogue

	Tuesday, 23 October 2018
	Event moderation: Séverine Rion Logean, Life & Health R&D Manager, Swiss Re
08.00	Welcome coffee
08.30	Welcome and introduction Justine Kelly-Fisher, Head L&H Business Management Client Service Delivery, Swiss Re
Topic	From science fiction to practice
08.35	Building an evidence base for the future of genomic medicine Robert Green, Geneticist, Brigham and Women's Hospital; Professor of Medicine, Harvard Medical School
08.55	Genome editing: What will the future bring? Rodger Novak, Co-Founder and President, CRISPR Therapeutics
09.15	(Nearly) 100,000 genomes later: What have we learned? Mark Bale, Head of Science Partnerships, Genomics England / Department of Health & Social Care, UK
09.35	Polygenic risk scores for risk assessment Richard Karlsson Linnér, Postdoctoral Researcher, School of Business and Economics, Vrije Universiteit Amsterdam
09.55	Panel discussion on the current status and future of genomic medicine: From early detection to cure Moderated by Christoph Nabholz, Head Life & Behaviour R&D, Swiss Re Mark Bale, Head of Science Partnerships, Genomics England / Department of Health & Social Care, UK Stefan Foser, Group International Scientific Director, Roche Thilo Schroeder, Partner, Nextech Invest Ltd.
10.35	Coffee break
11.00	Workshops Round 1 starts at 11:00 Round 2 starts at 11:30 Workshop session 1: Personalised medicine in the clinical practice and what it means for insurance Expert: Stefan Foser, Group International Scientific Director, Roche Moderator: Giselle Abangma, Senior L&H Research Analyst, Swiss Re Workshop session 2: Is reversal of genetic disease a reality? Risks and opportunities for insurance Expert: Rodger Novak, Co-Founder and President, CRISPR Therapeutics Moderator: Thomas Wildhaber, Financial Analyst, Swiss Re Workshop session 3: The cost and value of the interpretome Expert: Mark Bale, Head of Science Partnerships, Genomics England / Department of Health & Social Care, UK Moderator: Yommy Chiu, Life & Health R&D Manager, Swiss Re Workshop session 4: Polygenic risk scores vs. traditional risk factors in underwriting Expert: Pietro Biroli, Assistant Professor of Economics, University of Zurich and Richard Karlsson Linnér, Postdoctoral Researcher, School of Business and Economics, Vrije Universiteit Amsterdam Moderator: John Schoonbee, Global Chief Medical Officer, Swiss Re
12.00	Lunch
Topic	A look at today's practice
13.20	Precision medicine: A reality check Stefan Foser, Group International Scientific Director, Roche
13.40	The value proposition of genetic testing as an insurance offering Marko Bitenc, Founder and CEO, GenePlanet
14.00	Genetics and genomics: A view from daily practice in oncology today and tomorrow Beat Thürlimann, Head of Breast Center, Cantonal Hospital St. Gallen
14.20	Potential for genetic information to promote healthier behaviours Colleen McBride, Rollins Professor and Chair, Department of Behavioral Sciences & Health Education, Emory University
14.40	Panel discussion on the value proposition in insurance: How to motivate individuals to take action on information gained through genetic testing? Moderated by Lizzy Lubczanski, Behavioural Research Manager, Swiss Re Robert Green, Geneticist, Brigham and Women's Hospital; Professor of Medicine, Harvard Medical School Colleen McBride, Rollins Professor and Chair, Department of Behavioral Sciences & Health Education, Emory University Beat Thürlimann, Head of Breast Center, Cantonal Hospital St. Gallen
15.20	Coffee break
15.45	Workshops Round 1 starts at 15:45 Round 2 starts at 16:15 Workshop session 1: The impact of genomic medicine on behaviour and insurance Expert: Robert Green, Geneticist, Brigham and Women's Hospital; Professor of Medicine, Harvard Medical School Moderator: Florian Rechfeld, Senior Research Analyst L&H, Swiss Re Workshop session 2: Exploring the insurance value proposition of genetic testing Expert: Marko Bitenc, Founder and CEO, GenePlanet Moderator: Tsutomu Nemoto, Life & Behaviour Research Analyst, Swiss Re Workshop session 3: Challenges and dilemmas in clinical counselling Expert: Beat Thürlimann, Head of Breast Center, Cantonal Hospital St. Gallen Moderator: Monica Wilson, Chief Medical Officer, Swiss Re Workshop session 4: Potential for genetic information to promote healthier behaviours Expert: Colleen McBride, Rollins Professor and Chair, Department of Behavioral Sciences & Health Education, Emory University Moderator: Tiffany Zhang, Behavioural Research Consultant, Swiss Re
16.50	Closing remarks and next steps Christoph Nabholz, Head Life & Behaviour R&D, Swiss Re
17.00	End of event

This event may be photographed, filmed and/ or recorded. A summary of the event, pictures and/or a video of the event in which you may appear may be posted and made available on Swiss Re’s and the Swiss Re Centre for Global Dialogue’s internal and external websites and in printed materials.